Constellation Energy Has Crushed Investors in 2026: 75% Gains Are Coming According to One Pro Analyst on Wall Street

Constellation Energy trades at $254.02, down 27.77% year-to-date and near its $228.28 52-week low, despite raising guidance and posting adjusted Q2 EPS of $2.55 versus $2.33 consensus; revenue of $7.50B missed and operating income fell 39.01%. Scotiabank's $441 target implies 73.6% upside, while the $347.28 consensus target implies 36.7%, supported by 20%+ base EPS growth guidance through 2029, nuclear demand from AI data centers, and 920MW of new long-term nuclear contracts. The upside case depends on PJM/FERC resolving data-center co-location rules by mid-2027, the Crane nuclear restart occurring on schedule, and improving PJM capacity pricing; delays, ERCOT oversupply, and the May 2027 Illinois ZEC expiry remain key risks.

Analysis

CEG’s rerating hinges less on near-term EPS delivery than on converting scarce, dispatchable clean generation into long-duration contracted cash flows. Until contract pricing, load-interconnection treatment, and economics of the added generation portfolio are disclosed, investors are underwriting an option value rather than visible earnings; that explains why guidance beats alone have not arrested multiple compression. The key second-order issue is that a larger gas-and-battery footprint increases exposure to regional power-price volatility, potentially diluting the premium historically assigned to its nuclear fleet.

The principal 1-3 month catalyst is evidence that incremental hyperscaler demand is translating into signed contracts at attractive fixed-price escalators rather than merely pipeline commentary. The more material 6-18 month binary is regulatory clarity: a favorable PJM/FERC framework could unlock a scarcity premium across CEG, while a delay shifts attention to the May 2027 Illinois support-program cliff and restart execution risk. Buybacks support per-share metrics but will not offset a sustained de-rating if forward contracted gross margin remains opaque.

Consensus appears to treat CEG and VST as interchangeable AI-power proxies, but their regional exposure creates a potentially useful relative-value distinction. CEG has greater upside torque to PJM scarcity and contracted nuclear demand; VST is more vulnerable to an extended period in which incremental storage capacity arrives before load growth monetizes in ERCOT. Conversely, a prolonged regulatory process would favor neither pure AI-power narrative, and CEG’s premium valuation leaves it exposed if 2027 estimates continue to soften.

Key Decisions for Investors

• Initiate a starter long CEG position on weakness near current levels, sized at 50% of a normal position; target $335-$350 over 12-18 months if PJM contracting visibility improves, with a hard reassessment on a sustained break below $228 or a material reduction in 2027 EPS expectations.
• Use a CEG/VST relative-value watchlist rather than immediately deploying the pair: go long CEG and short VST only after PJM rulemaking has a credible timetable and ERCOT forward power curves remain weak. The trade requires updated regional hedge books, forward EBITDA estimates, and relative valuation data before establishing hedge ratios.
• Treat any announced large-load contract as a catalyst only if it discloses duration, price escalation, credit support, and incremental generation required. Contracts that merely extend existing output or lack pricing should not justify adding exposure.
• Reduce CEG exposure ahead of the Illinois support-program decision window unless replacement revenue is quantified. Thesis is falsified if regulatory relief is delayed beyond mid-2027, Crane timing slips materially, or contracted-margin guidance fails to offset the expected loss of support payments.